Summit Therapeutics Market Cap

Summit Therapeutics has a market cap or net worth of $6.10 billion as of May 31, 2024. Its market cap has increased by 408.05% in one year.

Market Cap

6.10B

Enterprise Value

6.04B

1-Year Change

408.05%

Ranking

#1130

Market Cap Chart

Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $6.10B, an increase of 5,023.23%. That is a compound annual growth rate of 53.07%.

Market Cap History

Date	Market Cap	% Change
May 31, 2024	6.10B	-20.47%
May 30, 2024	7.67B	272.06%
May 29, 2024	2.06B	22.81%
May 28, 2024	1.68B	-29.29%
May 24, 2024	2.37B	-21.76%
May 23, 2024	3.03B	-1.59%
May 22, 2024	3.08B	-
May 21, 2024	3.08B	-3.30%
May 20, 2024	3.19B	2.25%
May 17, 2024	3.12B	-1.55%
May 16, 2024	3.17B	0.44%
May 15, 2024	3.15B	-4.16%
May 14, 2024	3.29B	-2.40%
May 13, 2024	3.37B	3.23%
May 10, 2024	3.26B	-2.72%
May 9, 2024	3.36B	-3.63%
May 8, 2024	3.48B	-6.59%
May 7, 2024	3.73B	18.79%
May 6, 2024	3.14B	1.82%
May 3, 2024	3.08B	8.13%
May 2, 2024	2.85B	-13.62%
May 1, 2024	3.30B	19.64%
Apr 30, 2024	2.76B	1.29%
Apr 29, 2024	2.72B	0.52%
Apr 26, 2024	2.71B	8.74%

View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Revolution Medicines	6.45B
Acadia Healthcare Company	6.33B
Exelixis	6.24B
Grifols	5.95B
DENTSPLY SIRONA	5.83B
Lantheus Holdings	5.67B
Glaukos	5.63B
Cytokinetics	5.58B

Market Cap Rankings